Radiation Therapy

Radiation Therapy

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

GRACE is happy to present the 6th in our series ASCO 2016 Lung Cancer Roundtable , Highlights and New Approaches in Lung Cancer . Featuring Jack West...
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. Ross Camidge, University of Colorado, discusses management of CNS progression for ALK-positive NSCLC including monitoring frequency and preferences between systemic and radiation therapy.
Cancer Journey:
Cancer Type:
Dr. Nasser Hanna, Indiana University Health, addresses the issue of prophylactic cranial irradiation (PCI) in locally advanced NSCLC.
Cancer Journey:
Cancer Type:
Dr. Nasser Hanna, Indiana University Health, lists chemo regiments appropriate for use with radiation in locally advanced NSCLC.
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. Nasser Hanna, Indiana University Health, considers the use of induction or consolidation chemotherapy for unresectable stage III NSCLC.
Cancer Journey:
Cancer Type:

Articles

After completing my unpacking from ASCO and beginning to see a path of light as I dig out from under the backup of work that accumulated, I wanted to...
Cancer Journey:
Cancer Type:
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, defines the V20 standard for lung radiation and outlines the advantages of limiting dose and field size in lung radiation therapy.
Cancer Journey:
Cancer Type:
Disease Learning:
Drs. Ben Solomon, Leora Horn, & Jack West discuss whether the data highlighting cognitive deficits from whole brain radiation therapy (WBRT) for patients with brain metastases should change our recommendations for prophylactic cranial irradiation (PCI).
Cancer Journey:
Cancer Type:
Drs. Leora Horn, Ben Solomon, & Jack West debate whether results from a European trial of chest radiation after chemotherapy for extensive stage small cell lung cancer should lead to a change in treatment for this setting.
Cancer Journey:
Cancer Type:
Memorial Sloan-Kettering Cancer Center medical oncologist Dr. Greg Riely explains how testing for specific mutations in patients with advanced NSCLC can guide prognosis and treatment recommendations.
Cancer Journey:
Cancer Type:

Community Forum

My wife is experiencing a second time brain tumor recurrence. She had her first occipital craniotomy back in 2011. On late Oct 2013 she began to...
Cancer Journey:
Cancer Type:
This seems to be an option for everyone with brain metastases (inform your doctor as it is quite new) ) Here are links to research done in Spain in...
Cancer Journey:
Cancer Type: